Our Focus

Improving lives of patients facing challenges associated with injectable therapies for their rare or chronic diseases.

Our Mission

Chiasma is a clinical, late-stage biopharmaceutical company

dedicated to addressing the everyday challenges associated with existing therapies for rare and serious chronic diseases.

Persistence

Persistence

Resiliency in the face of challenges.

Passion for Results

Passion for Results

Integrity and energy to achieve superior results.

Ingenuity

Ingenuity

Technology to develop novel solutions.

Commitment to People

Commitment to People

Responsibility to patients, our community and our people.

Sense of Urgency

Sense of Urgency

Acting with speed, efficiency and accountability.

Our Foundation

Our proprietary Transient Permeability Enhancer (TPE®)

technology platform delivers important medicines in oral formulations that are designed to foster greater independence among patients with rare and chronic diseases.